Biocontrol of Clinical Bacteria Infecting Urinogenital System by Probiotic Bacteria | ||||
Egyptian Journal of Microbiology | ||||
Article 6, Volume 51, Issue 1, December 2016, Page 77-88 PDF (635.54 K) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/ejm.2017.361.1006 | ||||
View on SCiNiTO | ||||
Authors | ||||
Talaat El-Sayed1; Soheir Saad Abd El-Salam 2; Gamal Enan3; Ahmed Shahin4; Hytham M. Ahmed5 | ||||
1Department of Botany, Faculty of Science, Benha University | ||||
2Botany Department, Faculty of Science, Benha University | ||||
3Botany Department, Faculty of Science, Zagazig University | ||||
4Microbiology Department, Faculty of Medicine, Zagazig University | ||||
5Faculty of Science, Benha University | ||||
Abstract | ||||
Urinogenital infections proved to be one of the most common diseases which mankind can face nowadays. Both men and women can be infected by the urogenital pathogens but the last are considered more susceptible to these injuries due to their physiological nature. The emergence of multi-drug resistance phenomenon made the treatment with such antibiotics is useless. Urinary tract infection (UTI) caused by bacteria is considered one of the most frequent injuries infecting both male and female. The development of multi-drug resistance phenomenon in bacteria leads to the necessity of finding an alternative remedy. Probiotics are suggested as a suitable and appropriate solution. In this study, CFS of Lactobacillus plantarum LPS10 is examined for its inhibitory effect against clinical urogenital bacterial strains and Candida albicans isolated from UTI infections. CFS obtained from this probiotic showed a promising antibacterial and anticandidial results. L. plantarum LPS10 possessed the capability to be used as a probiotic against clinical bacteria isolated from urogenital infections. | ||||
Keywords | ||||
Urogenital infections; probiotics; Multi-drug resistance; Inhibitory effect | ||||
Statistics Article View: 1,249 PDF Download: 809 |
||||